Quick Answer
IRADIMED CORP reported Diluted EPS of $1.75 per share for fiscal year 2025.
IRADIMED CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.75 | +16.7% |
| 2024 | $1.50 | +11.1% |
| 2023 | $1.35 | +32.4% |
| 2022 | $1.02 | +37.8% |
| 2021 | $0.74 | +572.7% |
| 2020 | $0.11 | -85.9% |
| 2019 | $0.78 | +50.0% |
| 2018 | $0.52 | +1200.0% |
| 2017 | $0.04 | -93.3% |
| 2016 | $0.60 | +0.0% |
| 2015 | $0.60 | +200.0% |
| 2014 | $0.20 | -9.1% |
| 2013 | $0.22 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.43 | +7.5% | -4.4% |
| June 30, 2025 | $0.45 | +18.4% | +21.6% |
| March 31, 2025 | $0.37 | +15.6% | -7.5% |
| September 30, 2024 | $0.40 | +0.0% | +5.3% |
| June 30, 2024 | $0.38 | +15.2% | +18.8% |
| March 31, 2024 | $0.32 | +18.5% | -20.0% |
| September 30, 2023 | $0.40 | +48.1% | +21.2% |
| June 30, 2023 | $0.33 | +26.9% | +22.2% |
- IRADIMED CORP showed an increase of +16.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, IRADIMED CORP’s diluted eps has grown by 695.5% (from $0.22 per share to $1.75 per share).
- The most recent figure is from IRADIMED CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: